Chimera Investment Corp
CIM NYSE Real Estate Investment Trusts Financials FY2016–FY2025
Last close · Oct 23, 2026
$8.42
0.4%What Chimera Investment Corp does
No business description yet.
- Legal name
- CHIMERA INVESTMENT CORP
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K · Feb 18, 2026
- Accession · CIK
- 0001409493-26-000017
0001409493
Revenue and margins
Chimera Investment Corp had $266M of revenue in fiscal 2025, up 0.7% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew −5.7% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was — in fiscal 2025, — of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Chimera Investment Corp returned $123M to shareholders in fiscal 2025. The diluted share count rose 2.2%.
Balance sheet
Cash, debt and the ratios that show how comfortably Chimera Investment Corp can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $386M | $265M | $222M | $84.0M | $279M |
| Debt incl. finance leases | $0.0M | — | $0.0M | $135M | $252M |
| Debt / equity | 0.0x | — | 0.0x | 0.1x | 0.1x |
| Total assets | $15.4B | $13.4B | $12.9B | $13.1B | $15.8B |
| Total liabilities | $11.7B | $10.7B | $10.4B | $10.6B | $13.2B |
| Shareholders' equity | $3.7B | $2.7B | $2.6B | $2.5B | $2.6B |
| Net debt (− = net cash) | −$386M | — | −$222M | $50.6M | −$27.1M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. “Plan” marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
—
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8–9 is strong, 0–2 weak.
| Test | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Net income is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ | ✓ | ✓ | ✓ |
| Cash from operations is positive | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✓ | ✕ |
| Return on assets rose | — | ✕ | ✕ | ✓ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ |
| Cash from operations exceeds net income | ✓ | ✕ | ✕ | ✕ | ✓ | ✕ | ✓ | ✓ | ✓ | ✕ |
| Debt fell relative to assets | — | — | — | — | ✕ | ✓ | — | — | ✕ | ✕ |
| Current ratio rose | — | — | — | — | — | — | — | — | — | — |
| Share count didn't rise | — | ✕ | ✓ | ✕ | ✕ | ✕ | ✓ | ✓ | ✕ | ✕ |
| Gross margin rose | — | — | — | — | — | — | — | — | — | — |
| Revenue rose relative to assets | — | ✕ | ✕ | ✓ | ✓ | ✓ | ✕ | ✕ | ✕ | ✕ |
| F-score | — / 3 | — / 6 | — / 6 | — / 6 | 4 / 7 | 5 / 7 | — / 6 | — / 6 | 4 / 7 | 2 / 7 |
| Accruals ratio | −0.0% | 0.2% | 0.5% | 1.3% | −0.8% | 0.9% | −5.8% | −0.7% | −0.2% | 3.3% |
| Altman Z'' | — | — | — | — | — | — | — | — | — | — |
10 years of figures
Amounts in USD. Hover a ratio’s name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $586M | $606M | $594M | $602M | $514M | $611M | $440M | $263M | $265M | $266M |
| Net interest income | $586M | $606M | $594M | $602M | $514M | $611M | $440M | $263M | $265M | $266M |
| Interest expense | $348M | $533M | $679M | $759M | $516M | $327M | $333M | $510M | — | — |
| Pretax income | $552M | $525M | $412M | $414M | $89.0M | $675M | −$513M | $126M | $176M | $233M |
| Income tax | $0.1M | $0.1M | $0.1M | $0.2M | $0.2M | $4.4M | −$0.3M | $0.1M | $0.0M | $2.3M |
| Net income | $552M | $525M | $412M | $414M | $88.9M | $670M | −$513M | $126M | $176M | $230M |
| Net income to common | $549M | $491M | $368M | $341M | $15.1M | $596M | −$587M | $52.4M | $90.3M | $144M |
| Diluted EPS | $2.92 | $2.61 | $1.96 | $1.81 | $0.07 | $2.44 | −$7.53 | $0.68 | $1.10 | $1.72 |
| Diluted shares | 0.19B | 0.19B | 0.19B | 0.19B | 0.23B | 0.25B | 0.08B | 0.08B | 0.08B | 0.08B |
| Cash flow | ||||||||||
| Cash from operations | $553M | $487M | $298M | $65.0M | $258M | $519M | $326M | $213M | $206M | −$249M |
| Stock-based compensation | $2.0M | $4.0M | $8.8M | $10.6M | $5.0M | $6.5M | $8.2M | $9.6M | $10.1M | $9.7M |
| Share buybacks | $0.0M | $0.0M | $14.8M | $0.0M | $22.1M | $1.8M | $48.9M | $33.1M | $0.0M | $0.0M |
| Dividends paid | $454M | $376M | $374M | $374M | $323M | $299M | $288M | $195M | $119M | $123M |
| Dividends and buybacks | $454M | $376M | $389M | $374M | $345M | $300M | $337M | $228M | $119M | $123M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $178M | $63.6M | $47.5M | $110M | $269M | $386M | $265M | $222M | $84.0M | $279M |
| Total debt | — | — | — | $0.0M | $51.6M | $0.0M | — | $0.0M | $135M | $252M |
| Total assets | $16.7B | $21.2B | $27.7B | $27.1B | $17.5B | $15.4B | $13.4B | $12.9B | $13.1B | $15.8B |
| Total liabilities | $13.6B | $17.6B | $24.0B | $23.2B | $13.7B | $11.7B | $10.7B | $10.4B | $10.6B | $13.2B |
| Preferred stock | $0.1M | — | — | — | — | — | — | — | — | — |
| Shareholders' equity | $3.1B | $3.6B | $3.7B | $4.0B | $3.8B | $3.7B | $2.7B | $2.6B | $2.5B | $2.6B |
| Margins | ||||||||||
| Net margin | 94.2% | 86.6% | 69.3% | 68.7% | 17.3% | 109.7% | −116.7% | 47.9% | 66.5% | 86.5% |
| Net interest share of revenue | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Returns | ||||||||||
| Return on equity | 17.7% | 15.5% | 11.2% | 10.8% | 2.3% | 17.8% | −16.0% | 4.8% | 6.9% | 9.0% |
| Return on assets | 3.3% | 2.8% | 1.7% | 1.5% | 0.4% | 4.1% | −3.6% | 1.0% | 1.4% | 1.6% |
| Return on tangible equity | 17.6% | 13.5% | 9.9% | 8.6% | 0.4% | 16.0% | −22.0% | 2.0% | 3.6% | 5.6% |
| Growth | ||||||||||
| Revenue growth | — | 3.4% | −1.9% | 1.4% | −14.6% | 18.8% | −28.0% | −40.1% | 0.5% | 0.7% |
| Net income growth | — | −4.9% | −21.5% | 0.5% | −78.5% | 654.2% | −176.6% | — | 39.6% | 30.9% |
| EPS growth | — | −10.6% | −24.9% | −7.7% | −96.1% | 3,385.7% | −408.6% | — | 61.8% | 56.4% |
| Share count change | — | 0.1% | −0.3% | 0.4% | 20.2% | 8.4% | −68.2% | −0.6% | 6.0% | 2.2% |
| Financial health | ||||||||||
| Debt / equity | — | — | — | 0.0x | 0.0x | 0.0x | — | 0.0x | 0.1x | 0.1x |
| Capital allocation | ||||||||||
| Stock comp / revenue | 0.3% | 0.7% | 1.5% | 1.8% | 1.0% | 1.1% | 1.9% | 3.6% | 3.8% | 3.6% |
| Quality scores | ||||||||||
| Piotroski F-score | — | — | — | — | 4.0 | 5.0 | — | — | 4.0 | 2.0 |
| Accruals ratio | −0.0% | 0.2% | 0.5% | 1.3% | −0.8% | 0.9% | −5.8% | −0.7% | −0.2% | 3.3% |
Source: SEC EDGAR XBRL filings (CIK 0001409493). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only — not investment advice. Check the original filings before relying on any figure.
